STEPHEN ULRICH: Open Payments
NPI 1881670792 · NEW LEXINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 20 payments from 9 companies in 2025. Trend: 2023 $1,152 · 2024 $915 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $284 |
| Corcept Therapeutics | 4 | $71 |
| ABBVIE INC. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Abbott Laboratories | 1 | $20 |
| Viatris Specialty LLC | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
Products named: FARXIGA, AIRSUPRA, BREZTRI, Korlym, VRAYLAR, CAPLYTA, FREESTYLE LIBRE 3, YUPELRI.
Industry payments across OH — which companies pay providers there.
